Andrey Meshcheryakov

2.7k total citations
21 papers, 72 citations indexed

About

Andrey Meshcheryakov is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Andrey Meshcheryakov has authored 21 papers receiving a total of 72 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Andrey Meshcheryakov's work include Cancer Immunotherapy and Biomarkers (7 papers), Gastric Cancer Management and Outcomes (5 papers) and CAR-T cell therapy research (3 papers). Andrey Meshcheryakov is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Gastric Cancer Management and Outcomes (5 papers) and CAR-T cell therapy research (3 papers). Andrey Meshcheryakov collaborates with scholars based in Russia, United States and Belgium. Andrey Meshcheryakov's co-authors include Sergei A. Nedospasov, Maria A. Lagarkova, Yuriy V. Shebzukhov, Dmitry V. Kuprash, Mikhail Lichinitser, Ekaterina P. Koroleva, Elke Jäger, Alexander Christopher Jonathan Van Akkooi, Sandrine Marréaud and Matteo S. Carlino and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Oncology.

In The Last Decade

Andrey Meshcheryakov

15 papers receiving 67 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrey Meshcheryakov Russia 5 49 28 27 9 8 21 72
Karin Choquette United States 3 35 0.7× 28 1.0× 23 0.9× 13 1.4× 7 0.9× 3 74
Anushka De Costa United States 4 55 1.1× 30 1.1× 13 0.5× 16 1.8× 3 0.4× 7 69
Noriko Yasuda‐Yoshihara Japan 6 44 0.9× 31 1.1× 36 1.3× 10 1.1× 4 0.5× 7 86
May Ji United States 4 36 0.7× 17 0.6× 25 0.9× 10 1.1× 2 0.3× 4 63
Aleksandar Murgaski Belgium 5 42 0.9× 60 2.1× 34 1.3× 18 2.0× 4 0.5× 5 84
Simona Ruisi Italy 2 36 0.7× 20 0.7× 19 0.7× 3 0.3× 5 0.6× 2 71
Martina Milighetti United Kingdom 4 18 0.4× 22 0.8× 23 0.9× 7 0.8× 3 0.4× 8 54
A. Casado Herráez Spain 5 26 0.5× 21 0.8× 21 0.8× 12 1.3× 9 1.1× 11 70
Takamasa Ishino Japan 4 72 1.5× 69 2.5× 26 1.0× 5 0.6× 6 0.8× 11 122

Countries citing papers authored by Andrey Meshcheryakov

Since Specialization
Citations

This map shows the geographic impact of Andrey Meshcheryakov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrey Meshcheryakov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrey Meshcheryakov more than expected).

Fields of papers citing papers by Andrey Meshcheryakov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrey Meshcheryakov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrey Meshcheryakov. The network helps show where Andrey Meshcheryakov may publish in the future.

Co-authorship network of co-authors of Andrey Meshcheryakov

This figure shows the co-authorship network connecting the top 25 collaborators of Andrey Meshcheryakov. A scholar is included among the top collaborators of Andrey Meshcheryakov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrey Meshcheryakov. Andrey Meshcheryakov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Meshcheryakov, Andrey, et al.. (2022). Dynamic changes in the tumor microenvironment under the effect of estradiol as a diagnostic tool and target for targeted cancer therapy. SHILAP Revista de lepidopterología. 21(1). 171–182. 1 indexed citations
4.
Стилиди, И. С., et al.. (2021). Surgical and combined treatment of patients with duodenal stromal tumors. Pirogov Russian Journal of Surgery. 11–11.
5.
Meshcheryakov, Andrey, et al.. (2021). Gastrointestinal stromal duodenal tumors: diagnostic mistakes and modern approaches to treatment. Pirogov Russian Journal of Surgery. 125–125.
6.
Eggermont, Alexander M.M., Andrey Meshcheryakov, Victoria Atkinson, et al.. (2021). Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase 3 trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma.. Journal of Clinical Oncology. 39(15_suppl). 9500–9500. 3 indexed citations
7.
Карселадзе, А. И., et al.. (2020). Combined anti‑HER2 and hormonal treatment in a patient with HR+HER2+ clear‑cell uterine carcinoma: A case report. Molecular and Clinical Oncology. 14(1). 19–19. 1 indexed citations
8.
Zhukova, Lyudmila, et al.. (2020). ASSOCIATION OF NKT- AND ACTIVATED CD25<sup>+</sup> PERIPHERAL BLOOD LYMPHOCYTES WITH DISEASE FREE AND OVERALL SURVIVAL OF TRIPLE NEGATIVE BREAST CANCER PATIENTS. SHILAP Revista de lepidopterología. 19(6). 66–72. 1 indexed citations
9.
10.
Zhukova, Lyudmila, et al.. (2020). Efficacy and safety of cisplatin and paclitaxel (PlaTax regimen) in the neoadjuvant treatment of patients with stage II–III triple-negative breast cancer. SHILAP Revista de lepidopterología. 16(2). 25–37. 1 indexed citations
11.
12.
Zhukova, Lyudmila, et al.. (2020). Immunological predictive and prognostic factors in patients with stage II-III triple negative breast cancer.. Journal of Clinical Oncology. 38(15_suppl). e12581–e12581. 1 indexed citations
13.
Завалишина, Л Э, Yu Yu Andreeva, Г А Франк, et al.. (2019). Role of clustered amplification as a marker for a special sensitivity to neoadjuvant anti-HER2 therapy with trastuzumab in patients with stage II-III breast cancer. Russian Journal of Archive of Pathology. 81(6). 56–56. 2 indexed citations
14.
Tryakin, A., Anastasia Mochalova, Andrey Meshcheryakov, et al.. (2019). Ramucirumab in the treatment of refractory metastatic gastric cancer: Results from the RamSelGa trial. Annals of Oncology. 30. v306–v307. 1 indexed citations
15.
Meshcheryakov, Andrey, et al.. (2017). RESULT OF ARTHROSCOPY IN THE CENTER OF AMBULATORY SURGERY OKB G. KHANTY-MANSIYSK. 11(1). 19–20.
16.
Meshcheryakov, Andrey. (2017). PROPHYLAXIS AND TREATMENT OF SIDE EFFECTS OF ANTIANGIOGENIC THERAPY IN PATIENTS WITH METASTATIC COLORECTAL CARCINOMA. Russian Journal of Oncology. 22(3). 164–168. 1 indexed citations
17.
Крылов, В. В., et al.. (2015). Abdominal sepsis and oxidative stress. Pirogov Russian Journal of Surgery. 18–18. 4 indexed citations
18.
Yalçın, Şuayib, Andrey Meshcheryakov, Fadi Nasr, et al.. (2014). Personalized Treatment is Better than one Treatment Fits All in the Management of Patients with mCRC: A Consensus Statement. Future Oncology. 10(16). 2643–2657. 6 indexed citations
19.
Shebzukhov, Yuriy V., Ekaterina P. Koroleva, Fanny Longpré, et al.. (2005). Antibody response to a non‐conserved C‐terminal part of human histone deacetylase 3 in colon cancer patients. International Journal of Cancer. 117(5). 800–806. 15 indexed citations
20.
Shebzukhov, Yuriy V., Ekaterina P. Koroleva, Maria A. Lagarkova, et al.. (2005). Humoral immune response to thymidylate synthase in colon cancer patients after 5-FU chemotherapy. Immunology Letters. 100(1). 88–93. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Choquette Breakdown of academic impact, for papers by Anushka De Costa Breakdown of academic impact, for papers by Noriko Yasuda‐Yoshihara Breakdown of academic impact, for papers by May Ji Breakdown of academic impact, for papers by Aleksandar Murgaski Breakdown of academic impact, for papers by Simona Ruisi Breakdown of academic impact, for papers by Martina Milighetti Breakdown of academic impact, for papers by A. Casado Herráez Breakdown of academic impact, for papers by Takamasa Ishino
Rankless by CCL
2026